期刊文献+

MCP-1及IL-10在狼疮性肾炎及其相关疾病活动度的临床意义 被引量:5

Clinical Significance of Monocyte Chemoattractant Protein-1 and Intedeukin-10 in Patients with Lupus Nephritis and its Correlation with Disease Activity
下载PDF
导出
摘要 目的:分析活动期和静止期狼疮性肾炎(LN)患者血清和尿液标本中单核细胞趋化蛋白-1(MCP-1)和IL-10水平的变化并探讨其临床意义。方法:应用ELISA技术对活动期和静止期LN患者血清和尿液中MCP-1和IL-10进行检测,分析LN不同时期MCP-1和IL-10与其他相关指标之间的关系。结果:活动期患者尿液MCP-1水平显著地高于静止期患者,而血清MCP-1两者差异无统计学意义;活动期患者血清IL-10水平显著地高于静止期患者,而尿液IL-10两者差异无统计学意义。结论:尿液MCP-1和血清IL-10水平可能与LN活动存在一定的相关性,有望成为SLE肾脏损害及疗效观察的监测指标。 Objective To determine the change level in the serum and urine of MCP-1 and IL-IO of patients with lupus nephritis (LN) who are at aetive and resting stage as well as the two indicators clinical significance. Methods Serum and urine concentrationof MCP-land IL-IO were detected by enzyme-linked immunosorbent assay (ELISA) and their relations to other related indicators at dif- ferent stages were studied. Results Urine concentration of MCP-1 in active patients with lupus nephritis was significantly higher than that in resting ones, but there was no difference in serum. Serum concentration of IL-IO in active patients with lupus nephritis was ob- viously higher than that in resting ones, but there was no difference in urine. Conclusion The concentration of urine MCP-1 and ser- um IL-IO may have a certain correlation with lupus nephritis, it may be a useful parameter for monitoring of kidney damage and monito- ring the efficacy of treatment.
作者 摇顺华
出处 《放射免疫学杂志》 CAS 2012年第2期199-201,共3页 Journal of Radioimmanology
关键词 单核细胞趋化蛋白-1 白介素-10 狼疮性肾炎 系统性红斑狼疮 monocyte chemoattractant protein-1 ( MCP-1 ), interleukin-lO ( IL-IO), lupus nephritis ( LN), systemic lupus ery-thematosus (SLE)
  • 相关文献

参考文献6

二级参考文献13

  • 1周虹,胡伟新.肾组织细胞增殖细胞核抗原检测方法及临床意义[J].肾脏病与透析肾移植杂志,1995,4(3):298-299. 被引量:2
  • 2Mosmann TR,Fiorention DF,Bond MW.Tow types of mouse T help cell Ⅳ.Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.J EXP Med,1989,170:208
  • 3Park YB,Lee SK,Kim DS,et al.Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.Clin Exp Rhematol,1998,16:183
  • 4Austin H,Muenz L,Joyce KM,et al.Diffuse proliferative lupus nephritis:identification of specific pathologic features affecting renal outcome.Kidney Int,1984,25:689
  • 5Lan HY,Mu W,Nikolic-Paterson DJ,et al.A novel,simple,reliable,and sensitive method for multiple immunoenzyme staining use of microwave oven heating to block antibody crossreactivity and retrieve antigens.J Histochem,1995,43:97
  • 6Steven J,Chadban H,Tesch Y,et al.Effect of IL- 10 treatment on crescentic glomerulonephritis in rats.Kidney Int,1997,51:1809
  • 7Crawley E,Isenberg D,Woo P,et al.Interleukin-10 promoter polymorphism and lupus nephritis:comment on the article by Mok et al.1999,42(3) :590
  • 8Beebe AM,Cua DJ,de Waal Malefyt R.The role of interleukin-10 in autoimmune disease:systemic lupus erythematosus (SLE) and multiple sclerosis (MS).Cytokine & Growth Factor Reviews,2002,13:403
  • 9Ren K,Brentjens J,Chen Y,et al.Glomerular macrophage proliferation in experimental immune complex nephritis.Clin Immunol Immunopathol 1991,60:384
  • 10Uhm WS,Na K,Song GW,et al.Cytokine balance in kidney tissue from lupus nephritis patients.Rheumatology.2003,42(8):935

共引文献13

同被引文献73

  • 1周燕斌,李幼姬,谢灿茂,吴玉红.体外阻断CD134对LN患者外周血单个核细胞T_H1/T_H2细胞因子表达的影响[J].中华微生物学和免疫学杂志,2005,25(11):923-927. 被引量:1
  • 2吴哲,杨贺,李彦科.狼疮性肾炎的治疗进展[J].实用药物与临床,2006,9(4):257-258. 被引量:5
  • 3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 4Kulkarni 0, Pawar RD, Purschke W, et al. Spiegelmer inhibition of CCL2IMCP-l ameliorates lupus nephritis in MRL-(Fas)lpr mice[J].J Am Soc Nephrol, 2007, 18(8): 2350-2358.
  • 5Iikuni N, Okamoto H, Yoshio T, et al. Raised monocyte chemotactic protein-l (MCP-l)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus[J]. Ann Rheum Dis, 2006, 65(2): 253-256.
  • 6Radstake TR, van der Voort R, ten Brummelhuis M, et al. Increased expression of CCLl8, CCLl9, and CCL 17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fe gamma receptors[J]. Ann Rheumatic Dis, 2005, 64(3): 359-367.
  • 7Eriksson C, Eneslatt K, Ivanof[J, et al. Abnormal expression of chemokine receptors on T -cells from patients with systemic lupus erythematosus[J]. Lupus, 2003,12(10): 766-774.
  • 8Lit LC, Wong CK, Tam LS, et al. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus[J]. Ann Rheum Dis, 2006, 65(2): 209-215.
  • 9Lu XY, Zhu CQ, QianJ, et al. Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection[J]. Lupus, 2010,19(6): 689-695.
  • 10Singh RG, Usha, Rathore SS, et al. Urinary MCP-I as diagnostic and prognostic marker in patients with lupus nephritis flare[J]. Lupus, 2012,21(11): 1214-1218.

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部